Bortezomib-based therapy for relapsed/refractory multiple myeloma in real-world medical practice


Terpos E., Katodritou E., de la Rubia J., Hungria V., Hulin C., Roussou M., ...Daha Fazla

EUROPEAN JOURNAL OF HAEMATOLOGY, cilt.101, ss.556-565, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 101 Konu: 4
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1111/ejh.13147
  • Dergi Adı: EUROPEAN JOURNAL OF HAEMATOLOGY
  • Sayfa Sayıları: ss.556-565

Özet

Objective: The efficacy and safety of bortezomib-based therapy for relapsed/refractory multiple myeloma (RRMM) in clinical trials may differ from the oncology practice experience. The electronic VELCADE (R) OBservational Study was designed to prospectively evaluate bortezomib for multiple myeloma (MM) in real-world medical practice.